For oral drugs where reductions in bioavailability may well result in clinically important outcomes on its basic safety or efficacy, separate administration of ferric maltol from these medications. Length of separation may well rely upon the absorption of the medication concomitantly administered (eg, time to peak concentration, whether the drug is